NB-001 (Suzhou Luosheng Bio-Pharmaceutical)

NB001(逻晟生物)

Report date: 2026/05/15 20:01:45

Base Information

Drug NameNB-001 (Suzhou Luosheng Bio-Pharmaceutical)
Drug Alias NameNB-001NB-001 (Suzhou Luosheng Bio-Pharmaceutical)NB-001 (逻晟生物)NB 001NB001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoLogics Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A